Policy

Medicare Billing for Fertility Services: Coverage Rules and Compliance

Medicare excludes most fertility treatments, but misapplying the infertility exclusion costs practices revenue on legitimately covered diagnostics. Here's exactly what Medicare pays, what it doesn't, and how to protect your practice.

Jennifer Mitchell··10 min read

Medicare is the payer most fertility practices mishandle by applying a blanket "Medicare doesn't cover fertility" policy. The statutory exclusion is real — but it is narrower than most billers apply it, and the cost of over-applying it is lost revenue on legitimately covered diagnostic services. The cost of under-applying it is patient billing liability, overpayment demands, and OIG audit exposure. Neither error is acceptable, and both are preventable with a clear understanding of where Medicare's line actually falls.

The Statutory Exclusion: What the Law Actually Says

Medicare's exclusion of infertility services is codified at 42 CFR §411.15(f), which lists "services related to the diagnosis or treatment of infertility" as a statutory non-covered benefit. The critical legal phrase is "related to." CMS and the courts have interpreted this to mean services whose primary clinical purpose is the diagnosis or treatment of infertility as a reproductive condition — not every service ever rendered to a patient who happens to be infertile. A Medicare patient who presents with pelvic pain, abnormal uterine bleeding, or premature menopause symptoms has covered diagnostic needs regardless of whether she is also infertile. The documentation and diagnosis coding on your claim determine whether Medicare treats a service as infertility-related. If the primary diagnosis is female infertility (N97.x) or an encounter for procreative management (Z31.x), the claim will be denied as a statutory exclusion. If the primary diagnosis is pelvic pain (N94.x), ovarian cyst (N83.x), or abnormal uterine bleeding (N93.x), and the service is otherwise covered, Medicare will pay.

Services Medicare Will Not Cover

The following services are always non-covered by traditional Medicare regardless of documentation, because their clinical purpose is intrinsically reproductive:

  • IVF — oocyte retrieval (58970), embryo culture (89250, 89251), and embryo transfer (89253)
  • Intrauterine insemination — sperm washing (89260, 89261) and insemination procedures (58321, 58322, 58323)
  • Ovarian stimulation monitoring when the purpose is ART cycle management
  • Embryo cryopreservation (89258) and thawed embryo preparation (89352)
  • Oocyte cryopreservation (89337) and warming (89356)
  • Semen analysis billed as part of a male infertility workup (89300, 89310, 89320, 89321)
  • All preimplantation genetic testing — PGT-A (0362T), PGT-M (81443), PGT-SR (81228, 81229)
  • Endometrial receptivity array (ERA) — no Medicare-covered CPT code pathway exists
  • Mock embryo transfer — no separately billable CPT; excluded as IVF-preparatory
  • Trigger shot administration and monitoring within an ART stimulation protocol

These are statutory exclusions — always non-covered regardless of documentation. For Medicare beneficiaries receiving any of these services, an Advance Beneficiary Notice (ABN) must be on file before service delivery and the patient is responsible for the full charge. Submitting these claims to Medicare without a GY modifier generates unnecessary adjudication and flags your practice for payer scrutiny.

Diagnostic Services That Can Be Covered

Several services routinely performed in fertility practices are covered by Medicare when the documented indication is a covered medical condition. The same CPT code can be covered or non-covered depending solely on the primary diagnosis — which is why documentation drives billing outcomes for Medicare patients more than for any other payer.

ServiceCPT Code(s)Medicare Coverage StatusRequired Covered Indication
Pelvic ultrasound, complete76856Covered with qualifying dxPelvic pain, ovarian cyst, fibroid evaluation, AUB
Transvaginal ultrasound76830Covered with qualifying dxSymptomatic evaluation — pain, bleeding, structural finding
Saline infusion sonohysterography76831Covered for AUB evaluation; NOT for pre-IVF baselineAbnormal uterine bleeding, suspected polyp or fibroid
Diagnostic hysteroscopy58555CoveredAUB, suspected intrauterine pathology
Hysteroscopy with biopsy or polypectomy58558CoveredAUB, suspected polyp or endometrial pathology
Endometrial biopsy58100Covered for AUB evaluation; NOT for implantation timingAUB, rule out endometrial hyperplasia or malignancy
TSH, free T484443, 84439CoveredAmenorrhea, hypothyroid symptoms, menstrual irregularity
FSH, LH, estradiol83001, 83002, 82670Covered for menopause/POI dx; NOT for fertility workupSymptomatic POI, secondary amenorrhea, menopause evaluation
Prolactin84146CoveredAmenorrhea, galactorrhea, menstrual irregularity
DEXA scan77080Covered for POI with osteoporosis riskPOI meets Medicare DEXA screening criteria
Diagnostic laparoscopy49320CoveredPelvic pain, suspected endometriosis or adhesions
Laparoscopy with fulguration of endometriosis58662CoveredEndometriosis confirmed or highly suspected on evaluation
Anti-Müllerian hormone (AMH)83003NOT covered — no Medicare NCD or LCDN/A — always use ABN with GY or GA modifier
Semen analysis (fertility purpose)89300–89321NOT covered when fertility-relatedN/A — statutory exclusion applies regardless of indication

The ABN: Non-Negotiable Before Any Non-Covered Service

The Advance Beneficiary Notice of Noncoverage (ABN) — CMS form R-131 — is the legal instrument that transfers financial liability from the practice to the patient for non-covered services. Without a valid ABN, you cannot collect from the Medicare patient for any denied service, and you must write off the charge entirely. For fertility practices, this means every non-covered service rendered to a Medicare beneficiary must have a corresponding ABN in the chart before the service is provided — not after, not during, and not retroactively.

  • Use the current CMS-R-131 form — confirm the version date in the upper right corner against the CMS website; outdated versions are legally unenforceable
  • Deliver the ABN with enough advance time for the patient to make an informed decision — obtaining a signature while the patient is positioned for a procedure does not satisfy the voluntary advance notice standard
  • The form must include an itemized estimate of the expected charge for each non-covered service listed; blank dollar amount fields invalidate the ABN
  • The patient must select one of three options: (1) wants the service and agrees to pay; (2) wants the service and wants Medicare billed first; (3) does not want the service
  • Both the patient and a practice representative must sign and date the form; provide the patient with a copy and retain the original in the medical record
  • List each non-covered service by name — a generic "fertility services" description is insufficient when multiple distinct services are being rendered at the same encounter
  • Re-obtain the ABN for each new episode of care; a single ABN from a prior visit does not cover services rendered at a subsequent encounter

ABN Timing Is a Compliance Issue, Not a Courtesy

CMS requires the ABN to be delivered while the patient still has a genuine opportunity to decline the service. An ABN signed at the point of discharge or immediately post-procedure is legally unenforceable for patient billing purposes. Best practice: present the ABN at front-desk check-in, before clinical contact. Document the time of delivery in the chart. If a patient refuses to sign, note the refusal in the record, mark option 2 on the form, and document that the patient was verbally notified. Do not forge or backdate signatures under any circumstances — this converts a billing compliance issue into a federal fraud exposure.

Modifier Reference: GA, GY, and GZ

The modifier you apply when submitting a Medicare claim for an expected-denial service determines whether you can legally bill the patient afterward. Getting this wrong is one of the most consequential coding errors in Medicare billing for fertility practices:

ModifierFull NameWhen to UseCan You Bill the Patient?
GAWaiver of liability statement on fileService may not meet Medicare coverage criteria; valid ABN is on fileYes — per the terms the patient selected on the ABN
GYItem/service statutorily excludedService is always excluded by law regardless of indication (e.g., IVF, PGT, AMH)Yes — but requires patient financial agreement for opt-out providers
GZExpected denial; no ABN on fileService expected to be denied but NO ABN was obtained prior to serviceNo — must write off the full charge; do not bill the patient
59Distinct procedural serviceTwo or more procedures same date of service, different anatomical sites or sessionsN/A — not a coverage modifier
25Significant, separately identifiable E&ME&M and procedure on same date of service, different clinical problemsN/A — not a coverage modifier

The GZ modifier is your financial liability alarm: any claim submitted with GZ means you failed to obtain an ABN, the claim will be denied, and you have no legal basis to collect from the patient. Internal billing audits should flag every GZ claim for root-cause review. GZ should be a rare exception requiring documented explanation, not a routine occurrence in your monthly Medicare claims.

ICD-10 Coding Strategy for Medicare Claims

The primary diagnosis code is the first filter Medicare's adjudication system applies when evaluating coverage. Selecting the correct primary ICD-10 code based on the clinical encounter documentation — independent of the patient's reproductive history — is the most consequential billing decision for every Medicare claim generated by a fertility practice.

  • N97.0–N97.9 (Female infertility, all subcategories): Never use as primary diagnosis on a claim you expect Medicare to pay — these codes directly trigger the statutory infertility exclusion
  • Z31.x (Encounter for procreative management): Explicitly non-covered; submitting with a Z31 primary code generates an automatic statutory denial and should always have a GY modifier
  • N83.0–N83.9 (Non-inflammatory conditions of ovary, fallopian tube, and broad ligament): Use when the clinical indication is ovarian cyst, hydrosalpinx, or paratubal cyst evaluation
  • N80.x (Endometriosis): Use when pelvic pain, dysmenorrhea, or laparoscopic findings support the diagnosis as the primary reason for the encounter
  • N93.x (Other abnormal uterine and vaginal bleeding): Use when the primary complaint is AUB and a diagnostic service is performed to evaluate it
  • N94.x (Pain and other conditions associated with female genital organs and menstrual cycle): Covers dyspareunia, dysmenorrhea, and pelvic pain as primary clinical indications
  • E28.310–E28.319 (Premature ovarian failure/menopause): Use for POI diagnostic evaluation and long-term management — this is a covered medical condition distinct from infertility
  • E03.9 (Hypothyroidism, unspecified) and N91.2 (Secondary amenorrhea): Use when a thyroid panel is ordered to evaluate amenorrhea with documented hypothyroid etiology
  • R93.89 (Abnormal findings on diagnostic imaging of other specified body structures): Use when imaging reveals incidental structural findings requiring diagnostic follow-up

Premature Ovarian Insufficiency: A Covered Medical Diagnosis

Premature ovarian insufficiency (POI), coded as E28.310 (symptomatic premature menopause) or E28.319 (asymptomatic), is a medical condition with systemic health consequences — accelerated bone loss, cardiovascular risk, and neurological effects — that are entirely separate from its reproductive implications. Medicare covers the diagnosis and management of POI under standard Part B medical benefit rules, and fertility practices that see POI patients are fully entitled to bill for that covered medical care.

Covered services in a POI patient billed under E28.31x include: FSH and estradiol testing to confirm the diagnosis (83001, 82670); DEXA scan to assess bone mineral density (77080) — POI is a recognized Medicare DEXA indication under osteoporosis risk screening criteria; TSH and free T4 to rule out thyroid etiology for amenorrhea (84443, 84439); prolactin to rule out hyperprolactinemia (84146); office visits for HRT prescribing and management; and referral coordination to endocrinology or genetics. What remains non-covered even in a POI patient: oocyte retrieval, embryo culture, IVF, ART-directed monitoring cycles, and PGT. When a POI patient is receiving both medical management (covered) and fertility treatment (non-covered) in the same practice, document each encounter separately with its own primary diagnosis to prevent the covered services from being swept into the infertility exclusion.

Medicare Advantage vs. Traditional Medicare

Medicare Advantage (Part C) plans are commercially administered and can establish coverage rules that differ from traditional Medicare — including adding fertility benefits that traditional Medicare explicitly excludes. Some large MA plans, particularly those offered through employers to early retirees or through state Medicaid managed care expansions, have added limited fertility diagnostic coverage or even IVF benefits. You cannot assume that traditional Medicare's infertility exclusion applies to an MA plan beneficiary without verifying that plan's specific benefit structure.

  • Check the patient's insurance card for a private insurer name (Humana, UnitedHealthcare Medicare Advantage, Aetna Medicare, Cigna HealthSpring) — this signals an MA plan, not traditional Medicare
  • Call the MA plan's provider services line or use their provider portal to verify fertility benefit coverage before scheduling any service
  • Obtain prior authorization per the MA plan's requirements — MA authorization processes mirror commercial payers, not Medicare's fee-for-service system
  • MA plans issue their own EOBs and maintain their own fee schedules, which may differ significantly from the Medicare Physician Fee Schedule — verify contracted rates
  • Do not submit MA claims to the Medicare Fiscal Intermediary or MAC — submit directly to the MA plan's designated claims address
  • Appeals for MA plan denials follow the MA plan's grievance and appeals process, which differs from the traditional Medicare redetermination and QIC process

Secondary Insurance and Coordination of Benefits

Many Medicare patients carry secondary coverage — Medigap (Medicare Supplement) plans, employer retiree plans, or TRICARE for Life. The COB rules are straightforward but frequently misapplied in fertility practices. Medicare is always primary for patients eligible for Medicare, with limited exceptions for working-aged patients covered under active employer group health plans with 20 or more employees. Medigap plans mirror Medicare's coverage determinations: if Medicare denies a service as a statutory exclusion, the Medigap plan will not pay the patient's cost-sharing portion because Medicare never paid its share in the first place. An employer-sponsored secondary plan, however, may have independent fertility benefits. The correct workflow when a patient has Medicare primary and an employer secondary with fertility benefits: submit the claim to Medicare first with the GY modifier (statutory exclusion), obtain the Medicare denial EOB, then submit the claim to the secondary plan with the denial EOB attached. The secondary processes the claim on its own benefit rules and may pay what Medicare excluded. TRICARE for Life operates as secondary to Medicare and follows Medicare's same statutory infertility exclusion — TRICARE will not pay for services Medicare denied under 42 CFR §411.15(f).

Common Medicare Fertility Billing Errors

  • Billing non-covered fertility services without an ABN, then attempting to collect from the patient — this is a federal compliance violation under the Medicare secondary payer and beneficiary protection rules; write off the charge and immediately correct the intake process
  • Using N97.x (female infertility, any subcategory) as the primary diagnosis on any claim submitted to Medicare with an expectation of payment
  • Assuming all Medicare Advantage plans follow traditional Medicare's infertility exclusion — benefit structures vary by plan and must be verified individually
  • Submitting AMH (83003) to Medicare without a GY or GA modifier — AMH has no Medicare National Coverage Determination and will deny; an ABN is required before service delivery
  • Applying modifier GZ on a routine basis for non-covered claims — GZ means no ABN exists and no patient collection is permitted; every GZ claim should trigger a process review
  • Obtaining the ABN in the treatment room immediately before service rather than at front-desk check-in — CMS auditors treat same-time signatures as failing the voluntary advance notice standard
  • Bundling covered diagnostic services (pelvic pain ultrasound) with non-covered services (ovarian reserve panel) under a single claim and a fertility-related primary diagnosis — the fertility code contaminates the covered service
  • Treating a Medicare Advantage denial as a traditional Medicare statutory denial and failing to submit to employer secondary coverage under the MA plan's own COB rules

Provider Enrollment: The Prerequisite You Cannot Skip

Billing Medicare requires that the treating provider is enrolled in Medicare as a participating or non-participating provider, or has validly opted out via a signed opt-out affidavit filed with the local Medicare Administrative Contractor (MAC). Many fertility practices have never enrolled their REI physicians because they assumed Medicare was irrelevant to their specialty — and then a 44-year-old patient with POI or a postmenopausal woman seeking donor egg counseling presents, and the practice cannot bill for any service. Medicare enrollment through PECOS (Provider Enrollment, Chain, and Ownership System) typically takes 90 to 120 days to process. The effective date is the application submission date, not the approval date — meaning you can retroactively bill for covered services rendered after the application was submitted but before approval was granted, once enrollment is confirmed. Apply as soon as you identify that Medicare patients are presenting to the practice. For opt-out providers, the opt-out affidavit must be filed with the MAC before the first Medicare patient is seen under private contract. The private contract mechanism allows collection from patients for all services — covered and non-covered — but the contract must be patient-specific, written, and comply with CMS formatting requirements under 42 CFR §405.440. Opt-out is a valid approach for practices that will never bill Medicare for any service, but it requires correct execution to be legally enforceable.

Pre-Encounter Checklist for Medicare Beneficiaries

  • Verify whether the patient is enrolled in traditional Medicare or a Medicare Advantage plan — check the insurance card and run eligibility through your practice management system
  • If Medicare Advantage: call the plan for fertility benefit verification and authorization requirements before scheduling any service that might be fertility-related
  • Confirm the treating provider's Medicare enrollment status in PECOS — do not assume enrollment based on prior billing history; look it up
  • Review the planned services for the encounter and classify each as: (a) covered with qualifying clinical indication, (b) potentially covered depending on primary diagnosis selected, or (c) always non-covered requiring ABN
  • For all non-covered services: generate and deliver the ABN at front-desk check-in with itemized service descriptions and estimated charges before the patient enters the clinical area
  • Ensure the patient selects and signs one of the three ABN options; document delivery time in the chart
  • At claim submission: select primary ICD-10 based on documented clinical indication — not infertility history or reproductive goals
  • Apply GA modifier for services where a valid ABN is on file; GY modifier for always-excluded services; never use GZ unless genuinely no ABN exists and the write-off is accepted and documented
  • After denial on a GA-modifier claim: bill the patient per the ABN terms and reference the Medicare denial date and claim number on the patient statement
  • For patients with employer secondary coverage: submit to the secondary plan with the Medicare denial EOB attached after receiving the Medicare determination

Medicare billing in a fertility practice is a compliance discipline as much as a revenue function. The statutory exclusion is real and broad, but it has a defined legal edge — and everything outside that edge is billable with correct documentation and coding. Practices that train their billing staff to understand this distinction, maintain ABN compliance rigorously, and verify MA plan benefits before every encounter will find that Medicare is a manageable payer, not an automatic write-off. The practices that lose revenue and face compliance exposure are the ones applying a blanket infertility exclusion to services they are entitled to bill and collect — and the practices that face OIG scrutiny are the ones billing Medicare for services they know are excluded without the required ABN infrastructure to support patient collection.

Have a billing question?

Our team can answer questions specific to your practice's payer mix and procedures.

Book a Free Audit →